Kansarka beerka
Kansarka beerka waa buro caadi ah oo qani ku ah xididdada dhiigga, xididdada dhiigga ee burooyinka ayaa door muhiim ah ka ciyaara horumarinta kansarka beerka. Sidaa darteed, daaweynta hadda la beegsaday ee kansarka beerka waxaa lagu fuliyaa agagaarka anti-angiogenesis. Daaweynta ka hortagga angiogenesis-ka waa istaraatijiyad aad muhiim u ah dhaqanka bukaan-socodka ee kansarka beerka.
GUJI 2 TIJAABO
Tijaabada REACH-2 waxaa lagu fuliyaa iyadoo lagu salaynayo tijaabada REACH. Aqoonyahan Shiineys ah oo Mareykan ah Professor Andrew X. Zhu oo ka tirsan Isbitaalka Massachusetts ee ku xiran Jaamacadda Harvard ee Mareykanka ayaa u adeega sida PI-ga caalamiga ah. Wixii ah kansarka beerka Bukaannada ku guuldareystay inay daaweeyaan Sorafenib, isbarbardhigga Ramucirumab wuu ka duwan yahay placebo ee waxtarka daaweynta safka labaad, laakiin tijaabada ma aysan gaarin natiijooyinkii la filayay. Laakiin falanqaynteeda koox-hoosaadyadu waxay muujinaysaa in bukaannada qaba AFP (alfa-fetoprotein) in ka badan 400 ng / ml ay ka faa'iideysan karaan daaweynta Ramucirumab. Sidaa darteed, Professor Zhu wuxuu hoggaamiyay tijaabada REACH-2 wuxuuna ogaaday in Ramucirumab ay faa'iido u leedahay bukaanada labadaba guud ahaan badbaadada iyo horumarka aan horumarka lahayn marka la barbar dhigo placebo. Tijaabadani waxay leedahay muhiimad gaar ah, waxayna sii caddaynaysaa in daawaynta safka labaad ee kansarka beerka, daawaynta anti-angiogenesis ee unugyada difaaca jirka ee monoclonal macromolecular waxay gaari kartaa faa'iidooyin badbaado oo macne leh.
Waqtigan xaadirka ah, oxaliplatin ayaa loo ansixiyay qorshe daaweyn caadi ah oo gudaha iyo Yurub ah labadaba. Daawooyinka la beegsado molecule-yar, sorafenib iyo lenvatinib ayaa loo isticmaali karaa daawaynta safka hore, iyo regorafenib iyo carbotinib ayaa loo isticmaalaa daawaynta safka labaad. Daawooyinka molecule-ka waaweyn, Nivolumab iyo Ramucirumab labaduba waa Dooro daroogo.
Intaa waxaa dheer, bukaanno badan oo kansarka beerka qaba cagaarshow, iyo bukaan isku mid ah, isla xubin isku mid ah waqti isku mid ah, waxaa jira laba cudur oo gebi ahaanba kala duwan. Mid ka mid ah noocyada waa cudurada aasaasiga ah ee beerka, oo ay ku jiraan cagaarshow, haddii ay tahay cagaarshow fayras ah, ama cudur beerka khamriga ah, beerka dufanka leh, cirrhosis, waxaa jiri kara shaqo aan caadi ahayn oo beerka ah iyo dhibaatooyin kale. Qaybta labaad waa kansarka beerka oo aad u horumaray. Labadan cudur ayaa midba midka kale ku dhacaa oo waxay sameeyaan wareeg xun. Sidaa darteed, waxaa lagama maarmaan ah in la siiyo tixgelin habboon habka ogaanshaha iyo daaweynta, si looga hortago luminta midba midka kale. Sanadihii la soo dhaafay, waxaa la soo jeediyay in daawaynta ka hortagga fayraska iyo daaweynta ilaalinta beerka la sameeyo isku mar. Tani waa horumar kale oo laga sameeyay daawaynta kansarka beerka.
